Understanding Lyophilised Peptides

Lyophilisation, also called freeze-drying, is a process that removes water from a material by first freezing it and then placing it under low pressure so that the frozen water transitions directly from solid to vapour without passing through a liquid phase. This direct solid-to-gas transition is called sublimation. The result is a dry, stable solid that retains the chemical composition of the original material. The overview below describes the lyophilised format in factual terms and does not include guidance on any use of a material.

Freezing and primary drying

The material is first frozen at a sufficiently low temperature to solidify all the water it contains. It is then transferred to a freeze-dryer where the chamber pressure is reduced significantly. Under these conditions the ice sublimes: water vapour is drawn away while the material remains frozen. This primary drying stage removes the bulk of the water and accounts for most of the time in a typical lyophilisation cycle.

Secondary drying

After primary drying, a small amount of bound water remains in the material. Secondary drying, carried out at a higher temperature than the primary stage, removes this residual moisture to bring the material to a very low final water content. The moisture level achieved in secondary drying affects the long-term stability and handling characteristics of the finished material. For a more detailed treatment of the full freeze-drying cycle, see Understanding the Freeze-Drying Process.

Supplying a research peptide as a dry lyophilised powder offers practical advantages in a laboratory supply context. Dry material is substantially more stable than the same compound in solution, which means it can be stored at appropriate temperatures for extended periods without the stability concerns associated with keeping material dissolved. It can also be transported without the specialised refrigerated packaging required for solutions, and it arrives in a condition ready to be stored directly in the laboratory freezer.

The format also gives researchers flexibility. Lyophilised material allows the researcher to prepare solutions at the concentration and in the solvent suited to their own experimental protocol, rather than receiving material in a predetermined formulation. This flexibility is one reason the lyophilised format is standard for research-grade peptide supply.

Lyophilised research peptides are typically white to off-white in appearance, presenting as a powder or a loosely structured cake within a sealed vial. The exact appearance can vary: some materials form a more granular powder, others a more cohesive cake, and the appearance of a given material can differ slightly between batches depending on lyophilisation conditions. This visual variation is normal and does not necessarily indicate any change in composition.

Fine, lightweight powders are a common presentation. Fine powders can exhibit electrostatic behaviour, which is worth bearing in mind when opening vials and transferring material. General handling guidance for research materials in this form is covered in Research Material Handling Best Practices.

Lyophilised material is supplied in sealed vials, and the seal protects the dry material from air and moisture until the vial is opened. Keeping the vial sealed until use, and resealing it promptly after each access, limits cumulative exposure. Before opening a vial removed from cold storage, it is general good practice to allow it to reach approximately room temperature while still sealed, to reduce the risk of condensation forming on cold material when it contacts warm, humid air.

When a workflow calls for material in solution, researchers reconstitute the lyophilised powder by adding an appropriate solvent. The choice of solvent, the volume used, and the reconstitution approach are specific to each research context and are not prescribed here. General laboratory considerations for the reconstitution process, including solvent selection factors and preparation of working aliquots, are covered in Peptide Reconstitution Considerations.

Dry lyophilised material is generally kept frozen and protected from light between receipt and use. The storage condition stated on the product label and specification is the definitive reference for a specific material. General cold storage considerations are covered in Peptide Storage Guidelines. Available research peptides supplied in lyophilised form can be viewed in the catalogue, and our approach to material consistency is described on the Quality page.